A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Transitional Cell
  • Nomograms
  • Urologic Neoplasms

abstract

  • The RR and PFS6 vary as a function of baseline prognostic factors in patients receiving second-line therapy for advanced UC. A nomogram incorporating prognostic factors facilitates the evaluation of outcomes across phase II trials enrolling heterogeneous populations and helps select suitable agents for phase III testing.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/bju.12564

PubMed ID

  • 24219029

Additional Document Info

start page

  • E137

end page

  • 43

volume

  • 113

number

  • 5 B